CompletedPhase 1NCT02213094
Phase I Study of Nicotinamide for Early Onset Preeclampsia
Studying Preeclampsia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of North Carolina, Chapel Hill
- Principal Investigator
- Kim A Boggess, MDUniversity of North Carolina, Chapel Hill
- Intervention
- Nicotinamide 500 mg(drug)
- Enrollment
- 10 enrolled
- Eligibility
- 18-45 years · FEMALE
- Timeline
- 2014 – 2015
Study locations (1)
- University of North Carolina Women's Hospital, Chapel Hill, North Carolina, United States
Collaborators
North Carolina Translational and Clinical Sciences Institute
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02213094 on ClinicalTrials.govOther trials for Preeclampsia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07199283The PreEclampsia Postpartum Prevention TrialKarolinska Institutet
- RECRUITINGNCT06427408Longitudinal Study of Gene Expression in the Human Placenta During First-trimester and Full-term Pregnancy at the Single Cell LevelAssistance Publique - Hôpitaux de Paris
- RECRUITINGNCT07443345Incidence of Postoperative Diaphragmatic Dysfunction in Pregnant Women With PreeclampsiaCairo University
- RECRUITINGNANCT07209254Randomized Controlled Trial of Two Mobile Health Strategies to Manage Postpartum HypertensionJennifer Lewey, MD, MPH
- RECRUITINGPHASE2NCT06333652Ravulizumab in Pregnancies Complicated by Severe Hypertensive DisordersMayo Clinic
- RECRUITINGNCT07513558Preeclampsia: Origin, Characteristics and Effects on Mother and BabyMedical University of Graz
- RECRUITINGNCT06464159New Therapeutic Strategy Against PreeclampsiaAssistance Publique - Hôpitaux de Paris
- RECRUITINGNANCT06953115Vagal Stimulation Therapy and PreeclampsiaFundación Internacional René Mey